Friday, May 3, 2013

Growth in MedDevice Revenues, But Small Growth

Just 3%.  Not the kind of growth that inspires new entrants into a field and venture capital ivestment.  But that was the conlcusion of  our recent report on the medical device industry.   The global medical device market reached 331 billion dollars in 2012    Those companies that did growth launched new products or acquired companies with novel products.
In the U.S. Medicare, Medicaid, as well as state governments implemented anemic spending increases to hospitals, the key buyer of medical device products.   The cuts took the form of non payment for patients for infections acquired at the hospital, or code recovery fees.   In Europe, the extreme economic downturn in Spain, Ireland, Greece and Portugal  led to layoffs and proposed reforms to the health care systems.. Even emerging markets have grown spending less quickly than had been expected.  Hospitals continued to purchase through group organizations and insist on transparent prices. 
The beginning of 2013 saw the medical device industry make the first payments to the IRS for a new 2.3% excise tax on all classes of medical devices, as part of the 2009 Patient Protection and Affordable Care Act (referred to in this report as US healthcare reform.) Many companies attributed layoffs to the tax in widely-publicized announcements, or said that they would not build additional U.S. facilities.  Kalorama didn’t think the device tax factored into slow growth in 2012, but the report does predict long-term effects on venture capital investment and research spending in the industry.
In a slower-growing device market, there was little room for new entrants and giants dominated.  Johnson & Johnson is the world’s largest medical device company, followed by imaging giants GE Healthcare and Siemens and cardiology and spinal device expert Medtronic.  Other leading companies were Stryker, Covidien and Philips. 
Emerging markets were a key strategy for leaders and the report notes a new trend last year: the acquisition of Chinese local companies by device giants. Johnson & Johnson acquired local Chinese company Guangzhou Bioseal Biotechnology Co. Ltd, while Medtronic announced it would acquire China Kanghui Holdings, a developer and producer of trauma and spine orthopedic transplants.
The full report, The Global Market for Medical Devices, 4th Edition covers these trends, lists company revenues and provides estimates of specific device markets.  The report is available from Kalorama Information at